LABRITTANY DAVIS: Open Payments
NPI 1770927402 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,486 in 23 payments from 9 companies in 2025. Trend: 2023 $853 · 2024 $422 · 2025 $1,486
Food & beverage: $924Consulting: $563
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $727 |
| PFIZER INC. | 3 | $171 |
| GlaxoSmithKline, LLC. | 4 | $169 |
| Astellas Pharma US Inc | 3 | $165 |
| Merck Sharp & Dohme LLC | 3 | $85 |
| AstraZeneca Pharmaceuticals LP | 2 | $54 |
| Caris MPI, Inc. | 2 | $50 |
| Eisai Inc. | 2 | $47 |
| Coherus Oncology, Inc. | 1 | $19 |
Products named: ELAHERE, Veozah, ELREXFIO, LYNPARZA, JEMPERLI, TIVDAK, MI CANCER SEEK, Lenvima.
Industry payments across GA — which companies pay providers there.
